No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
YungShin Global Holding Corporation, through its various subsidiaries, engages in strategic investments, production, and distribution across a diverse portfolio. Its primary focus lies in the manufacturing and sale of human and veterinary pharmaceuticals, agricultural chemicals, industrial medical products, and cosmetics. The company maintains a significant market presence in Taiwan, Mainland China, Japan, and the United States. Beyond these core areas, YungShin also processes and markets wood products. Its operations include the development and sale of over-the-counter medications, specialized preparations, and chemical intermediates. Furthermore, the corporation offers a range of pharmaceutical services, such as research and development, technology transfer, licensing, and outsourcing, alongside general import and export trading activities. The company's commercial reach extends to the wholesale, retail, and broader trading of health products, beauty items, medical supplies, human testing reagents, and all associated raw materials, semi-finished goods, and manufacturing equipment. Established in 1952, YungShin Global Holding Corporation is headquartered in Taichung, Taiwan.
www.yungshingroup.comNo one on the platform currently holds 3705.TW.
No tracked institution reports a position in 3705.TW as of their last filing.
No one on the platform has traded 3705.TW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 3705.TWYungShin Global Holding Corporation | $56.00 | +0.00% | $14.9B | — |
| 1707.TWGrape King Bio Ltd | $86.50 | +0.23% | $12.8B | — |
| 1720.TWStandard Chem & Pharm Co. Ltd. | $55.80 | -0.53% | $11.0B | — |
| 1789.TWScinoPharm Taiwan, Ltd. | $18.10 | +0.00% | $14.3B | — |
| 4104.TWExcelsior Medical Co., Ltd. | $71.80 | +0.14% | $13.5B | — |
| 4105.TWOTTY Biopharm Company Limited | $78.20 | -0.13% | $19.4B | — |
| 4114.TWOSynmosa Biopharma Corporation | $29.45 | +0.34% | $15.9B | — |
Source: Financial Modeling Prep · peers by sector/industry